Literature DB >> 32915980

Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism.

Parth Patel1, Payal Patel2, Meha Bhatt3, Cody Braun4, Housne Begum3, Wojtek Wiercioch3, Jamie Varghese1, David Wooldridge1, Hani Alturkmani1, Merrill Thomas1, Mariam Baig1, Waled Bahaj1, Rasha Khatib5, Rohan Kehar6, Rakesh Ponnapureddy1, Anchal Sethi1, Ahmad Mustafa1, Wendy Lim7,8, Grégoire Le Gal9, Shannon M Bates10, Linda B Haramati11,12, Jeffrey Kline13, Eddy Lang14, Marc Righini15, Mohamad A Kalot16, Nedaa M Husainat16, Yazan Nayif Al Jabiri17, Holger J Schünemann3,18, Reem A Mustafa3,16.   

Abstract

Pulmonary embolism (PE) is a common, potentially life-threatening yet treatable condition. Prompt diagnosis and expeditious therapeutic intervention is of paramount importance for optimal patient management. Our objective was to systematically review the accuracy of D-dimer assay, compression ultrasonography (CUS), computed tomography pulmonary angiography (CTPA), and ventilation-perfusion (V/Q) scanning for the diagnosis of suspected first and recurrent PE. We searched Cochrane Central, MEDLINE, and EMBASE for eligible studies, reference lists of relevant reviews, registered trials, and relevant conference proceedings. 2 investigators screened and abstracted data. Risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies-2 and certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation framework. We pooled estimates of sensitivity and specificity. The review included 61 studies. The pooled estimates for D-dimer sensitivity and specificity were 0.97 (95% confidence interval [CI], 0.96-0.98) and 0.41 (95% CI, 0.36-0.46) respectively, whereas CTPA sensitivity and specificity were 0.94 (95% CI, 0.89-0.97) and 0.98 (95% CI, 0.97-0.99), respectively, and CUS sensitivity and specificity were 0.49 (95% CI, 0.31-0.66) and 0.96 (95% CI, 0.95-0.98), respectively. Three variations of pooled estimates for sensitivity and specificity of V/Q scan were carried out, based on interpretation of test results. D-dimer had the highest sensitivity when compared with imaging. CTPA and V/Q scans (high probability scan as a positive and low/non-diagnostic/normal scan as negative) both had the highest specificity. This systematic review was registered on PROSPERO as CRD42018084669.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32915980      PMCID: PMC7509887          DOI: 10.1182/bloodadvances.2019001052

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  76 in total

1.  [Association of D-dimer and helicoidal thoracic scanner for diagnosis of pulmonary embolism. Prospective study of 106 ambulatory patients].

Authors:  G Pacouret; O Marie; D Alison; B Delahousse; O Fichaux; P Peycher; D Djeffal Vincentelli; J M Potier; Y Gruel; B Charbonnier
Journal:  Presse Med       Date:  2002-01-12       Impact factor: 1.228

2.  GRADE: assessing the quality of evidence for diagnostic recommendations.

Authors:  Holger J Schünemann; Andrew D Oxman; Jan Brozek; Paul Glasziou; Patrick Bossuyt; Stephanie Chang; Paola Muti; Roman Jaeschke; Gordon H Guyatt
Journal:  ACP J Club       Date:  2008-12-16

3.  Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism.

Authors:  E Oger; C Leroyer; L Bressollette; M Nonent; E Le Moigne; Y Bizais; J Amiral; M Grimaux; J Clavier; P Ill; J F Abgrall; D Mottier
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

4.  Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful?

Authors:  M R Mac Gillavry; B J Sanson; H R Büller; D P Brandjes
Journal:  Thromb Haemost       Date:  2000-12       Impact factor: 5.249

5.  Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism.

Authors:  F Turkstra; P M Kuijer; E J van Beek; D P Brandjes; J W ten Cate; H R Büller
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

6.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

7.  Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.

Authors:  S M Bates; S Takach Lapner; J D Douketis; C Kearon; J Julian; S Parpia; S Schulman; J I Weitz; L A Linkins; M Crowther; W Lim; F A Spencer; A Y Y Lee; P L Gross; J Ginsberg
Journal:  J Thromb Haemost       Date:  2016-02-05       Impact factor: 5.824

8.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Authors:  Marc Righini; Josien Van Es; Paul L Den Exter; Pierre-Marie Roy; Franck Verschuren; Alexandre Ghuysen; Olivier T Rutschmann; Olivier Sanchez; Morgan Jaffrelot; Albert Trinh-Duc; Catherine Le Gall; Farès Moustafa; Alessandra Principe; Anja A Van Houten; Marije Ten Wolde; Renée A Douma; Germa Hazelaar; Petra M G Erkens; Klaas W Van Kralingen; Marco J J H Grootenboers; Marc F Durian; Y Whitney Cheung; Guy Meyer; Henri Bounameaux; Menno V Huisman; Pieter W Kamphuisen; Grégoire Le Gal
Journal:  JAMA       Date:  2014-03-19       Impact factor: 56.272

9.  Withholding anticoagulation after a negative computed tomography pulmonary angiogram as a stand-alone imaging investigation: a prospective management study.

Authors:  R M Subramaniam; D Blair; K Gilbert; G Coltman; J Sleigh; N Karalus
Journal:  Intern Med J       Date:  2007-06-02       Impact factor: 2.048

10.  Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.

Authors:  Gilles Pernod; Haifeng Wu; Emmanuel de Maistre; John Lazarchick; Jeannine Kassis; Carlos Aguilar; Pascual M Vera; Gualtiero Palareti; Armando D'Angelo
Journal:  Blood Coagul Fibrinolysis       Date:  2017-04       Impact factor: 1.276

View more
  6 in total

1.  Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism.

Authors:  Parth Patel; Payal Patel; Meha Bhatt; Cody Braun; Housne Begum; Robby Nieuwlaat; Rasha Khatib; Carolina C Martins; Yuan Zhang; Itziar Etxeandia-Ikobaltzeta; Jamie Varghese; Hani Alturkmani; Waled Bahaj; Mariam Baig; Rohan Kehar; Ahmad Mustafa; Rakesh Ponnapureddy; Anchal Sethi; Merrill Thomas; David Wooldridge; Wendy Lim; Shannon M Bates; Eddy Lang; Grégoire Le Gal; Linda B Haramati; Jeffrey Kline; Marc Righini; Wojtek Wiercioch; Holger Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-04-27

Review 2.  Diagnosing pulmonary thromboembolism: Concerns and controversies.

Authors:  Jyotindu Debnath; Vivek Sharma
Journal:  Med J Armed Forces India       Date:  2021-07-31

3.  Utility of Lung Perfusion SPECT/CT in Detection of Pulmonary Thromboembolic Disease: Outcome Analysis.

Authors:  Teik Hin Tan; Rosmadi Ismail
Journal:  Nucl Med Mol Imaging       Date:  2022-01-06

4.  GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask.

Authors:  Damir Janigro; Stefania Mondello; Jussi P Posti; Johan Unden
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

5.  D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29).

Authors:  Geoffrey K Isbister; Tina Noutsos; Shane Jenkins; Katherine Z Isoardi; Jessamine Soderstrom; Nicholas A Buckley
Journal:  Med J Aust       Date:  2022-06-07       Impact factor: 12.776

6.  Diagnostic accuracy of multiorgan point-of-care ultrasound compared with pulmonary computed tomographic angiogram in critically ill patients with suspected pulmonary embolism.

Authors:  Adriana M Girardi; Eduardo E Turra; Melina Loreto; Regis Albuquerque; Tiago S Garcia; Tatiana H Rech; Marcelo B Gazzana
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.